Syndecan-1 (CD 138) surface expression marks cell type and differentiation in ameloblastoma, keratocystic odontogenic tumor, and dentigerous cyst

Journal of Oral Pathology and Medicine

Volumn 42, Issue 2, 2013, Pages 186-193

  Al Otaibi, Ohoud ^a   Khounganian, Rita ^a   Anil, Sukumaran ^a   Rajendran, Ravindranath ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Bone disease; Cyst; Odontogenic tumor

Indexed keywords

BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; SYNDECAN 1;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ARTICLE; CELL TYPE; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; NEWBORN; ODONTOGENIC KERATOCYST; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; STELLATE CELL; TERATOMA; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; AMELOBLASTS; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CHILD; CONNECTIVE TISSUE CELLS; CYTOPLASM; DENTIGEROUS CYST; EPITHELIAL CELLS; FEMALE; HUMANS; KERATINOCYTES; MALE; MANDIBULAR DISEASES; MANDIBULAR NEOPLASMS; MAXILLARY DISEASES; MAXILLARY NEOPLASMS; MIDDLE AGED; MOUTH MUCOSA; ODONTOGENIC TUMORS; PLASMA CELLS; PROGNOSIS; STROMAL CELLS; SYNDECAN-1; YOUNG ADULT;

EID: 84873267549     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01195.x     Document Type: Article

References (36)

1. Saunders S, Jalkanen M, O'Farrell S, et al.Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 1989; 108: 1547-56.
2. Rapraeger A, Jalkanen M, Bernfield M. Integral membrane proteoglycans as matrix receptors: role in cytoskeleton and matrix assembly at the epithelial cell surface. In: Wight TN, Mecham RP, eds. The biology of the extracellular matrix: a series. Biology of proteoglycans. Orlando: Academic Press, 1987; 129-54.
3. Bernfield M, Kokenyesi R, Kato M, et al.Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8: 365-93.
4. Kato M, Bernfield M. Polymorphism of syndecan. A distinctive form on mesenchymal cells. J Cell Biol 1989; 109: 320a.
5. Salmivirta M, Elenius K, Vainio S, et al.Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 1991; 266: 7733-9.
6. Elenius K, Vainio S, Laato M, et al.Induced expression of syndecan in healing wounds. J Cell Biol 1991; 114: 585-95.
7. Underhill CB, Keller JM. A transformation-dependent difference in the heparan sulfate associated with the cell surface. Biochem Biophys Res Commun 1975; 63: 448-54.
8. Inki P, Stenback F, Talve L, et al.Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 1991; 139: 1333-40.
9. Jalkanen M, Rapraeger A, Saunders S, et al.Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol 1987; 105: 3087-96.
10. Kumamoto H. Molecular pathology of odontogenic tumors. J Oral Pathol Med 2006; 35: 65-74.
11. Gomes CC, Duarte AP, Diniz MG, et al.Review article: current concepts of ameloblastoma pathogenesis. J Oral Pathol Med 2010; 39: 585-91.
12. Barnes L, Eveson JW, Reichart P, et al.Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 306-7.
13. Kramer IR, Pindborg JJ, Shear M. The WHO Histological Typing of Odontogenic Tumours. A commentary on the Second Edition. Cancer 1992; 70: 2988-94.
14. Daley TD, Wysocki GP. The small dentigerous cyst. A diagnostic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 77-81.
15. Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol 2009; 45: 706-11.
16. Conover WJ. Practical nonparametric statistics. New York: Wiley, 1999; viii, 584 p.
17. Buck CA, Horwitz AF. Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol 1987; 3: 179-205.
18. Rapraeger AC. Syndecan-regulated receptor signaling. J Cell Biol 2000; 149: 995-8.
19. Thesleff I, Jalkanen M, Vainio S, et al.Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol 1988; 129: 565-72.
20. Liu W, Litwack ED, Stanley MJ, et al.Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem 1998; 273: 22825-32.
21. Soukka T, Pohjola J, Inki P, et al.Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med 2000; 29: 308-13.
22. Leocata P, Villari D, Fazzari C, et al.Syndecan-1 and Wingless-type protein-1 in human ameloblastomas. J Oral Pathol Med 2007; 36: 394-9.
23. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55: 1037-57.
24. Kurokawa H, Matsumoto S, Murata T, et al.Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 2003; 32: 513-21.
25. Nadalin MR, Fregnani ER, Silva-Sousa YT, et al.Syndecan-1 (CD138) and Ki-67 expression in odontogenic cystic lesions. Braz Dent J 2011; 22: 223-9.
26. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, et al.Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int 2009; 59: 229-33.
27. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, et al.Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008; 44: 805-11.
28. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001; 1471: M99-108.
29. Nagatsuka H, Han PP, Tsujigiwa H, et al.Heparanase gene and protein expression in ameloblastoma: possible role in local invasion of tumor cells. Oral Oncol 2005; 41: 542-8.
30. Pinheiro JJ, Freitas VM, Moretti AI, et al.Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 2004; 45: 65-72.
31. Kurokawa H, Zhang M, Matsumoto S, et al.Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathol Med 2006; 35: 301-6.
32. Hayashi K, Hayashi M, Jalkanen M, et al.Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem 1987; 35: 1079-88.
33. Davies EJ, Blackhall FH, Shanks JH, et al.Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin Cancer Res 2004; 10: 5178-86.
34. Mennerich D, Vogel A, Klaman I, et al.Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer 2004; 40: 1373-82.
35. Kato M, Saunders S, Nguyen H, et al.Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell 1995; 6: 559-76.
36. Jiang R, Kato M, Bernfield M, et al.Expression of syndecan-1 changes during the differentiation of visceral and parietal endoderm from murine F9 teratocarcinoma cells. Differentiation 1995; 59: 225-33.